520C9 [520C9.C3B10T]
520C9 [520C9.C3B10T]
规格:
货期:
编号:TS212846
品牌:Testobio
| 产品名称： | 520C9 520C9.C3B10T |
|---|---|
| 商品货号： | TS212846 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | Cancer,Cancer |
| Applications： | By immunofluorescence, the antibody is specific for neoplastic breast tissue with some weak cross-reaction with other neoplasms. The antibody reacts with a 210000 dalton protein found in cancerous human breast tissue. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against human breast cancer cells |
| Cellular Products： | immunoglobulin; monoclonal antibody; against human breast cancer cells |
| Tumorigenic： | Yes |
| Effects： | Yes, forms ascites in BALB/c mice |
| Comments： | Animals were immunized either with live cells or with membrane extracts from human breast cancer cell lines. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. By immunofluorescence, the antibody is specific for neoplastic breast tissue with some weak cross-reaction with other neoplasms. The antibody reacts with a 210000 dalton protein found in cancerous human breast tissue. |
| Complete Growth Medium： | Culture Medium: Dulbeccos modified Eagles medium (containing: 0.2 units/mL insulin, 1 mM Na pyruvate, 0.15 mg/mL oxaloacetic acid), with 4.5 g/L glucose, 60%; NCTC 109 medium, 20%; fetal bovine serum, 20%. |
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype： | IgG1 |
| Name of Depositor： | Cetus Corp. |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| U.S. Patent Number： | |
| References： | Ring DB, et al. Monoclonal anti-human breast cancer antibodies. US Patent 4,753,894 dated Jun 28 1988 Tempest PR, et al. Humanized antibodies to Fc receptors for immunoglobulin G on human mononuclear phagocytes. US Patent 6,500,931 dated Dec 31 2002 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
520C9 [520C9.C3B10T]
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | 520C9 520C9.C3B10T |
|---|---|
| 商品货号： | TS212846 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | Cancer,Cancer |
| Applications： | By immunofluorescence, the antibody is specific for neoplastic breast tissue with some weak cross-reaction with other neoplasms. The antibody reacts with a 210000 dalton protein found in cancerous human breast tissue. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against human breast cancer cells |
| Cellular Products： | immunoglobulin; monoclonal antibody; against human breast cancer cells |
| Tumorigenic： | Yes |
| Effects： | Yes, forms ascites in BALB/c mice |
| Comments： | Animals were immunized either with live cells or with membrane extracts from human breast cancer cell lines. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. By immunofluorescence, the antibody is specific for neoplastic breast tissue with some weak cross-reaction with other neoplasms. The antibody reacts with a 210000 dalton protein found in cancerous human breast tissue. |
| Complete Growth Medium： | Culture Medium: Dulbeccos modified Eagles medium (containing: 0.2 units/mL insulin, 1 mM Na pyruvate, 0.15 mg/mL oxaloacetic acid), with 4.5 g/L glucose, 60%; NCTC 109 medium, 20%; fetal bovine serum, 20%. |
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype： | IgG1 |
| Name of Depositor： | Cetus Corp. |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| U.S. Patent Number： | |
| References： | Ring DB, et al. Monoclonal anti-human breast cancer antibodies. US Patent 4,753,894 dated Jun 28 1988 Tempest PR, et al. Humanized antibodies to Fc receptors for immunoglobulin G on human mononuclear phagocytes. US Patent 6,500,931 dated Dec 31 2002 |
